A bullseye from 24 feet? COVID-19 vaccine timelines are overly hopeful, analyst says

Americans have been told daily that researchers are urgently working on COVID-19 vaccines, and that one might be available in 12 to 18 months. That timeline has made its way to high levels of government and through national media coverage.

But one influential biopharma analyst doesn't buy it—and he has plenty of reasons why.